NOBILIS HEALTH CORP. (TSE:NHC) Files An 8-K Entry into a Material Definitive Agreement

Northstar Healthcare Acquisitions, L.L.C. (the Borrower), a
Delaware limited liability company and wholly owned subsidiary of
Nobilis Health Corp. (the Company), entered into the Amendment
No. 1 to BBVA Credit Agreement and Waiver, dated as of March 3,
2017, by and among the Borrower, the Company, certain
subsidiaries of the Company parties thereto, the lenders from
time to time parties thereto (the Lenders), BBVA Compass Bank as
Administrative Agent, LC Issuing Lender and Swingline Lender, and
LegacyTexas Bank as LC Issuing Lender (the Amendment). The
purpose of the Amendment was to; (i) modify the definition of
Permitted Acquisition to require Lender approval and consent for
any acquisition which is closing during the 2017 fiscal year;
(ii) modify certain financial definitions and covenants,
including, but not limited to, an increase to the maximum
Consolidated Leverage Ratio to 3.75 to 1.00 for the period
beginning September 30, 2016 and ending September 30, 2017, and
an increase to the Consolidated Fixed Charge Coverage Ratio to
1.15 to 1.00 for the period beginning September 30, 2016 and
ending June 30, 2017; (iii) waive the Pro Forma Leverage
Requirement in connection with the previously reported Hamilton
Vein Center acquisition; and (iv) provide each Lenders consent to
the Hamilton Vein Center acquisition. The Amendment also
contained a limited waiver of a specified event of default.

A copy of the Amendment is attached as Exhibit 10.1 to this
Current Report on Form 8-K and incorporated herein by reference.
The description of the Amendment in this Current Report is a
summary and is qualified in its entirety by reference to the
complete text of such Amendment.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.